Search clinical trials for: Oxcarbazepine

Total 66 results

Novartis Pharmaceuticals

Completed

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Bipolar Disorder

United States, France, Russian Federation
Novartis Pharmaceuticals

Completed

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Bipolar Disorder

United States, Austria, Canada, Colombia, Czech Republic, Germany, Guatemala, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela
Novartis

Completed

Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Bipolar Disorder

Austria, Canada, Czech Republic, Germany, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela, United States, Colombia, Guatemala
Novartis

Completed

Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of Licarbazepine

Healthy

Czech Republic
Novartis

Completed

Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine

Healthy

Czech Republic
Novartis

Completed

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder

Bipolar I Disorder
Novartis

Completed

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.

Bipolar I Disorder

United States
Collaborative Care Initiative, LLC
Dauten Family Center for Bipolar Treatment Innovation, Massachusetts Gen...

Unknown

Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression

Bipolar Depression | Treatment Effectiveness | Measure-based Guidance

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Prostate Cancer Foundation

Completed

Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer

Prostate Cancer

United States
Desitin Arzneimittel GmbH
FGK Clinical Research GmbH

Terminated

EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy

Partial Epilepsy

Germany
Novartis Pharmaceuticals

Completed

Pediatric Epilepsy Study

Epilepsy | Epilepsies, Partial

United States, Germany, Brazil, Mexico
Novartis Pharmaceuticals

Completed

Pediatric Epilepsy Study

Epilepsy

United States, Germany, Brazil, Mexico
Supernus Pharmaceuticals, Inc.

Completed

Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy

Partial Epilepsy

United States, Poland, Bulgaria, Romania, Canada, Russian Federation, Mexico, Croatia
Novartis Pharmaceuticals

Completed

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Bipolar Disorder

United States
Supernus Pharmaceuticals, Inc.

Approved for marketing

Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects

Epilepsy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions

Healthy

India
Supernus Pharmaceuticals, Inc.

Completed

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

Epilepsies, Partial

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition

Healthy

India
Bial - Portela C S.A.

Completed

Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine

Epilepsy

Germany
Supernus Pharmaceuticals, Inc.
Parexel

Completed

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures (PROSPER1)

Epilepsies, Partial

United States, Poland, Mexico, Bulgaria, Romania, Canada, Russian Federation, Croatia
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Torsemide Tablets Under Fed Conditions

Healthy
Odense University Hospital
Novartis; Danish Research Agency

Completed

Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.

Metabolic Clearance Rate

Denmark
Ju Seok Ryu

Completed

Symptom Based Treatment of Neuropathic Pain

Neuralgia | Spinal Cord Injury

Korea, Republic of
Novartis

Completed

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.

Bipolar Disorder
Mario Negri Institute for Pharmacological Research
Ministry of Health, Italy; Azienda Ospedaliera San Gerardo di Monza

Active, not recruiting

Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) (STANDLOW)

Epilepsies, Partial

Italy
Roxane Laboratories

Completed

Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions

Epilepsy | Seizures

Canada
Novartis

Completed

Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures

Epilepsy, Partial Seizures

Russian Federation
Centre of Chinese Medicine, Georgia
Rea Rehabilitation Centre, Georgia

Completed

Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma

Bronchial Asthma
Sykehuset Innlandet HF

Completed

The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)

Agitation Aggression in Dementia

Norway
Roxane Laboratories

Completed

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions

Epilepsy | Seizures

United States
Novartis

Completed

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.

Conduct Disorder
Søren H. Sindrup
Danish Pain Research Center; Innovative Medicines Initiative

Completed

Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain (IMIOXC)

Postherpetic Neuralgia | Peripheral Nerve Injury | Polyneuropathy

Denmark
Nobelpharma

Completed

Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Partial Onset Seizures

Japan
Teva Pharmaceuticals USA

Completed

Oxcarbazepine 600 mg Tablets Under Fasting Conditions

Healthy

Canada
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions

Seizures

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions

Seizures

United States
All India Institute of Medical Sciences, Bhubaneswar

Completed

Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder

Bipolar Disorder

India
Roxane Laboratories

Completed

Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions

Epilepsy | Seizures

Canada
Novartis

Completed

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

Epilepsy, Partial Seizures

Russian Federation
Queen Mary University of London
Novartis Pharmaceuticals; University College, London; Barts & The London NHS... and other collaborators

Completed

Protective Role of Oxcarbazepine in Multiple Sclerosis (PROXIMUS)

Multiple Sclerosis

United Kingdom
Teva Pharmaceuticals USA

Completed

Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Sarfez Pharmaceuticals, Inc.

Completed

A Food Effect Study of 60mg ER Torsemide

Food-drug Interaction

India
Korea UCB Co., Ltd.

Completed

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (OPTIMAL)

Epilepsy

Korea, Republic of
Bial - Portela C S.A.

Completed

Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

Epilepsy

Portugal
University of Medicine and Dentistry of New Jersey
National Alliance for Research on Schizophrenia and Depression

Completed

Oxcarbazepine Versus Placebo in Childhood Autism

Autism

United States
Bial - Portela C S.A.

Completed

Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

Epilepsy

Portugal
University of Colorado, Denver

Withdrawn

Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia

Trigeminal Neuralgia
Assiut University

Unknown

Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes

Benign Childhood Epilepsy With Centrotemporal Spikes

Egypt
Bial - Portela C S.A.

Completed

Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine

Partial Epilepsy

Belgium
All India Institute of Medical Sciences, Bhubaneswar

Completed

Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures

Seizures, Focal

India

3

Subscribe